15th World Congress on Cancer Therapy, Biomarkers & Clinical Research
Philadelphia, USA
Ying Mu
Center for Devices and Radiological Health-US FDA, USA
Biography
Dr. Mu has completed his Ph.D. from Gunma University/Japan and postdoctoral studies at Kyoto University, Carnegie Mellon University and University of Pittsburgh. He is the board certified toxicologist (D.A.B.T.) and a principal investigate at the FDA. He has published more than 25 papers in reputed journals and is interested in the development of biomarkers for allergic risk assessment.
Abstract
Abstract : Biomarker development for allergic risk assessment
